Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.10 and traded as high as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 1,600 shares changing hands.
Resverlogix Stock Performance
The stock has a fifty day simple moving average of C$0.10 and a two-hundred day simple moving average of C$0.10. The company has a debt-to-equity ratio of -82.47, a quick ratio of 0.04 and a current ratio of 0.04. The stock has a market capitalization of C$32.71 million, a price-to-earnings ratio of -2.38 and a beta of 0.12.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
